ARV — Arvida Income Statement
0.000.00%
HealthcareBalancedMid Cap
- NZ$1.24bn
- NZ$3.72bn
- NZ$247.16m
Annual income statement for Arvida, fiscal year end - March 31st, NZD millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 164 | 174 | 202 | 222 | 247 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 141 | 41.5 | 3.91 | 138 | 101 |
Operating Profit | 22.3 | 133 | 198 | 83.9 | 146 |
Net Income Before Taxes | 22.3 | 133 | 198 | 83.9 | 146 |
Provision for Income Taxes | |||||
Net Income After Taxes | 42.6 | 131 | 199 | 82.5 | 139 |
Net Income Before Extraordinary Items | |||||
Net Income | 42.6 | 131 | 199 | 82.5 | 139 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 42.6 | 131 | 199 | 82.5 | 139 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.107 | 0.244 | 0.339 | 0.092 | 0.176 |
Dividends per Share | |||||
Special Dividends per Share |